Peninsula Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,544
Closed -$308K 77
2023
Q1
$308K Buy
7,544
+3,384
+81% +$146K 0.09% 58
2022
Q4
$213K Buy
+4,160
New +$199K 0.07% 68
2022
Q3
Sell
-5,882
Closed -$308K 73
2022
Q2
$308K Buy
5,882
+215
+4% +$11K 0.1% 47
2022
Q1
$293K Sell
5,667
-103
-2% -$5.34K 0.08% 53
2021
Q4
$341K Buy
+5,770
New +$286K 0.09% 49

Other funds holding PFE

Peninsula Wealth's PFE Position: Q2 2023 in Review

Peninsula Wealth sold out of Pfizer (PFE) in Q2 2023, closing a stake of 7,544 shares — an estimated $308K sold.

Peninsula Wealth first reported a position in PFE in Q4 2021 and held it in 5 quarters. The position peaked at $341K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Peninsula Wealth reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • Peninsula Wealth sold 7,544 Pfizer shares in Q2 2023, an estimated $308K.
  • Peninsula Wealth first reported a position in Pfizer in Q4 2021 and held it in 5 quarters.
  • Peninsula Wealth's Pfizer position peaked at $341K in Q4 2021.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Peninsula Wealth's 13F filing for Q2 2023, filed 14 Aug 2023.